<DOC>
	<DOCNO>NCT01367899</DOCNO>
	<brief_summary>The objective post-approval study provide scientifically valid reliable evidence support claim long term safety effectiveness regard Month 120 device survivorship rate .</brief_summary>
	<brief_title>CONSERVE Plus Post-Approval Study ( PAS )</brief_title>
	<detailed_description>This study evaluate performance CONSERVE Plus Hip Resurfacing System actual condition use . Additionally , study evaluate performance device post approval environment see significant change device performance compare pre-market IDE Study</detailed_description>
	<criteria>1 . Was previously enrol CONSERVEÂ® Plus IDE part All Enrolled Audited Cohort ( N=1366 procedure ( 1206 patient ) ) receive `` Original Shell '' . 2 . Is willing able comply study plan able understand sign Patient Informed Consent Form . 1 . Patient mentally incompetent . 2 . Patient prisoner . 3 . Patient alcohol and/or drug abuser 4 . Patient undergone device revision removal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Efficacy</keyword>
</DOC>